Extended-Release Naltrexone To Prevent Relapse Among Opioid Dependent, Criminal Justice System Involved Adults: Rationale and Design of a Randomized Controlled Effectiveness Trial

BACKGROUND: Extended-release naltrexone (XR-NTX, Vivitrol® Alkermes Inc.) is an injectable monthly sustained-release mu opioid receptor antagonist. XR-NTX is a potentially effective intervention for opioid use disorders and as relapse prevention among criminal justice system (CJS) populations. METHO...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Contemp Clin Trials
Hlavní autoři: Lee, Joshua D., Friedmann, Peter D., Boney, Tamara Y., Hoskinson, Randall A., McDonald, Ryan, Gordon, Michael, Fishman, Marc, Chen, Donna T., Bonnie, Richard J., Kinlock, Timothy W., Nunes, Edward V., Cornish, James W., O’Brien, Charles P.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4380547/
https://ncbi.nlm.nih.gov/pubmed/25602580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2015.01.005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky